In Dan Goodwin’s final episode as host, The Climate Biotech Podcast reflects on over 30 episodes of conversations with scientists, entrepreneurs, and builders at the frontier of climate biotechnology, and marks the official handover of the podcast to Homeworld Collective's new Executive Director and co-founder, Paul Reginato.

Dan and Paul trace their partnership back to MIT, where they were both developing first-of-kind spatial genomics technologies in Ed Boyden and George Church's labs. What started as a shared drive to work on climate change grew into organic community building, and eventually into Homeworld Collective, an organization designed to connect climate biotech practitioners with high-leverage problems, collaborators, and funding.

The episode distills wisdom from the podcast's guests so far. When asked what shaped them as thinkers, guests overwhelmingly cited science fiction and art over technical papers. On mentor advice, the theme was self-advocacy: pick hard problems, learn to communicate your work, and trust your own intuition. And when asked where a magic wand of climate biotech should point, answers ranged from better field measurements for methane to the largely untapped interface between geology and biology.

At the end of the episode, Paul shares his vision for Homeworld's phase two: refinement and scaling of Homeworld’s methods through more community convenings, a new ambassador program, faster production of problem statements, and more focused grantmaking designed to nucleate productive research communities in underserved, high-impact problem spaces. Dan reflects on his framework for choosing what comes next and highlights the underappreciated connection between environmental pollutants and the 70-80% of human disease that remains sporadic and unexplained.

Listen for the best career advice for early-career scientists, like "nail your projects, don't pick your track,” what a tadpole losing its tail teaches us about growth, and why building friendships across disciplinary boundaries can unlock your own potential to impact some of the most important problems of our time.

Send a text

On the most recent episode of the Climate Biotech Podcast, we are joined by Ginger Krieg Dosier, an architect-turned-biotech entrepreneur who created biocement at Biomason and is now building BIOME Consortia to accelerate biology's transition from thousands to billions of applications. Ginger's journey from NASA kid in Alabama to founding one of climate biotech's earliest companies reveals how architectural thinking translates surprisingly well to biological innovation.

Ginger’s approach at Biomasontackled concrete, the second most consumed substance on Earth after water. By using microbes to precipitate calcium carbonate at ambient temperature instead of firing kilns at 1500°C, they cut both emissions and energy usage dramatically.

The pivot to BIOME emerged from a startling statistic: with an estimated one trillion microbial species on Earth and only 0.001% discovered, Ginger saw that the strain bank they'd built for biocement applications represented something far bigger. Today, fewer than 800 strains power all commercial applications - she believes we need billions by 2050.

BIOME’s two flagship initiatives address this gap. Atlas creates a digital microbial commons focused on access and interpretability, gamifying discovery and translation to engage more tinkerers. Arc tackles preservation, particularly of threatened environments like glaciers that lose tens of quadrillions of microbes to sea annually, while moving beyond minus-80 storage limitations.

Listen to learn why consortia-based biology may solve the scaling economics that sank many biomanufacturing companies, how visualization of the invisible microbiome could transform public engagement, and why the "age of complexity" might finally deliver on the 1999 prediction that the 21st century would be biology's era.

Send a text

In this special episode, we sit down with Shuguang Zhang, Head of the Laboratory of Molecular Architecture in the MIT Media Lab and a mentor to countless biotech explorers. His personal story has at least one literal "1 in 100 Million" moment and demonstrates the power of curiosity, kindness, and always asking questions.

We trace how Shuguang's stubbornness to pursue questions long after others give up has taken him around the world and reshaped biology. "Why is some DNA left-handed?" is a question he couldn't stop asking as a young man in China. It led him to work with one of his heroes, Alexander Rich at MIT, where he discovered zoutin (from the Chinese word for left, 左, zuo), the critical protein for mysterious Z-DNA. When he purified this new protein, he became fascinated by how it self-assembled into structures visible to the naked eye—a discovery that became PuraMatrix, now used in wound healing worldwide, and sparked generations of curiosity about self-assembling peptides.

Similarly, wondering why there are both hydrophobic and hydrophilic alpha helices led to the QTY code: a beautifully simple method to convert any membrane protein into a water-soluble form. By swapping hydrophobic residues for polar look-alikes (Q, T, and Y) without breaking geometry, this unlocks dense high-signal sensors, "molecular trap" therapeutics targeting cancer metastasis, and a fresh way to treat receptors as modular parts rather than fragile mysteries.

The pattern repeats with S-layer proteins: nature's two-dimensional crystalline lattices that orient engineered receptors 100% upright at nanometer precision. Combined with QTY-solubilized proteins, these create clean bioelectronic interfaces, ultrasensitive arrays, and new possibilities for separations and chemical monitoring.

We widen the lens to climate: industrial-scale kelp systems for carbon capture and feed, biotech routes for ocean-based materials, and practical paths to planetary solutions that borrow from biology's atomic precision and self-assembly. Kelp's exceptional photosynthetic efficiency and rapid growth make it a promising system that biotechnology could enhance through genetic engineering.

Threaded through it all are lessons from mentors like Francis Crick ("ask big questions, you get bigger answers") and Alexander Rich ("it's equally important to know what not to do"). As Shuguang puts it: "In doing science, we see a lot of things, but don't observe. To observe is to pay attention." We also talk frankly about funding setbacks, debt, persistence, and the role of AI: powerful at pattern completion, weak at original curiosity.

If you care about proteins, materials, sensors, climate biotech, or simply how a life of questioning can bend reality, this conversation is a field guide.

If the story resonates, subscribe, share with a friend, and leave a review with the one question this episode inspired you to ask next.

Read Shuguang's powerful essay "Life Has Ups and Downs, but Always Ask Questions": https://www.researchgate.net/publication/363521718_Life_Has_Ups_and_Downs_but_Always_Ask_Questions

Send a text